American National Insurance’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $264K | Sell |
3,425
-865
| -20% | -$66.7K | 0.07% | 238 |
|
|
2021
Q4 | $379K | Sell |
4,290
-23,700
| -85% | -$2.09M | 0.08% | 227 |
|
|
2021
Q3 | $2.16M | Sell |
27,990
-30
| -0.1% | -$2.32K | 0.08% | 208 |
|
|
2021
Q2 | $2.34M | Sell |
28,020
-50
| -0.2% | -$4.17K | 0.09% | 207 |
|
|
2021
Q1 | $2.12M | Sell |
28,070
-25
| -0.1% | -$1.89K | 0.09% | 207 |
|
|
2020
Q4 | $2.46M | Hold |
28,095
| – | – | 0.11% | 189 |
|
|
2020
Q3 | $2.14M | Hold |
28,095
| – | – | 0.1% | 184 |
|
|
2020
Q2 | $3.47M | Hold |
28,095
| – | – | 0.18% | 143 |
|
|
2020
Q1 | $2.37M | Hold |
28,095
| – | – | 0.15% | 154 |
|
|
2019
Q4 | $2.38M | Hold |
28,095
| – | – | 0.12% | 173 |
|
|
2019
Q3 | $1.89M | Hold |
28,095
| – | – | 0.1% | 185 |
|
|
2019
Q2 | $2.41M | Hold |
28,095
| – | – | 0.13% | 174 |
|
|
2019
Q1 | $2.5M | Hold |
28,095
| – | – | 0.13% | 173 |
|
|
2018
Q4 | $2.39M | Hold |
28,095
| – | – | 0.14% | 165 |
|
|
2018
Q3 | $2.72M | Hold |
28,095
| – | – | 0.13% | 169 |
|
|
2018
Q2 | $2.65M | Hold |
28,095
| – | – | 0.13% | 178 |
|
|
2018
Q1 | $2.28M | Hold |
28,095
| – | – | 0.12% | 186 |
|
|
2017
Q4 | $2.51M | Hold |
28,095
| – | – | 0.13% | 183 |
|
|
2017
Q3 | $2.62M | Hold |
28,095
| – | – | 0.14% | 179 |
|
|
2017
Q2 | $2.55M | Hold |
28,095
| – | – | 0.14% | 175 |
|
|
2017
Q1 | $2.47M | Hold |
28,095
| – | – | 0.14% | 179 |
|
|
2016
Q4 | $2.33M | Hold |
28,095
| – | – | 0.14% | 178 |
|
|
2016
Q3 | $2.6M | Hold |
28,095
| – | – | 0.15% | 178 |
|
|
2016
Q2 | $2.19M | Hold |
28,095
| – | – | 0.13% | 196 |
|
|
2016
Q1 | $2.32M | Sell |
28,095
-105
| -0.4% | -$8.66K | 0.14% | 188 |
|
|
2015
Q4 | $2.95M | Buy |
+28,200
| New | +$2.95M | 0.18% | 161 |
|